Home › NDC Lookup › Ingredients › Bisacodyl › 00574-7050-12
Bisacodyl 10 mg Suppository, 12 suppositories — NDC 00574-7050-12 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Bisacodyl 10 mg Suppository, 12 suppositories — NDC 0574-7050-12 (Billing 00574-7050-12)

by Padagis US LLC · 12 BLISTER PACK in 1 CARTON / 1 SUPPOSITORY in 1 BLISTER PACK

This is a package of 12 suppositories of Bisacodyl 10 mg Suppository from Padagis US LLC, marketed since Sep 1990 and currently FDA-listed; retail pharmacies pay about $0.3197 per suppositorie (NADAC).

NDC 00574-7050-12
🏷️ FDA NDC (as labeled) 0574-7050-12 billing pads the labeler segment with a zero
This package
Contains12 suppositories Cost per ea$0.3197 NADAC Per package$3.84 / 12 suppository Pack sizes2 compare ↓
Also priced by: Medicaid pays $0.6733/unit — full pricing hub ↓
Product page 00574-7050-50 Also comes in: 50 suppositories 0574-7050-50
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0574-7050-12
Product NDC 0574-7050
11-digit billing NDC 00574705012
NCPDP billing unit EA — each (per item)
RxCUI 198509
UNII 10X0709Y6I
Application # M007
SPL Set ID 7eada0fc-5f83-43da-a56f-b0f537298208
Established class (EPC) Stimulant Laxative
Physiologic effect Increased Large Intestinal Motility; Stimulation Large Intestine Fluid/Electrolyte Secretion
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 1990-09-01
Route RECTAL
Dosage form SUPPOSITORY
Substance BISACODYL

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 46200010005205
GPI class Bisacodyl
GCN Seq No 002944
GCN 08731
HICL code 001301
Ingredient (HICL) Bisacodyl
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q3
Therapeutic class — intermediate (HIC2) Anal-Rectal Preparations
HIC3 code Q3S
Therapeutic class — specific (HIC3) Laxatives, Local/Rectal
AHFS code 56:12.00.00
AHFS class Cathartics And Laxatives
FDB label name BISACODYL 10 MG SUPPOSITORY
FDB brand name Bisacodyl
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 002944
  • GCN: 08731
  • GPI-14 (Medi-Span): 46200010005205
  • HICL (First Databank): 001301
  • AHFS class code: 56:12.00.00
  • RxCUI (RxNorm): 198509
Why two NDCs? The FDA registers this code as 0574-7050-12 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00574-7050-12. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Stimulant Laxative class.

Pharmacologic class Stimulant Laxative
Drug family (ATC) Contact laxatives, Enemas
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name BISACODYL 10 MG SUPPOSITORY Ingredient Bisacodyl
📖 What it is MedlinePlus · NLM

Rectal bisacodyl is used on a short-term basis to treat constipation. It also is used to empty the bowels before surgery and certain medical procedures. Bisacodyl is in a class of medications called stimulant laxatives. It works by increasing activity of the intestines to cause a bowel movement.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It relieves occasional constipation and irregularity. The Fleet enema is also used for fecal impaction and to clear residue after a barium test. It is meant for short-term use.
  • It depends on the form. Tablets usually work in 6 to 12 hours. Suppositories usually work in 15 minutes to 1 hour. The Fleet enema usually works in 5 to 20 minutes.
  • Not right away. Wait at least 1 hour after an antacid or milk before taking tablets. Swallow tablets whole with water and do not chew or crush them.
  • Can I take the tablets with an antacid or milk?
📖 Read our full Bisacodyl guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.320 $3.84 / 12 suppository
Medicaid paysCMS SDUD · 12 mo $0.6733 $8.08 / 12 suppository
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Jan 2022 Aug 2022 Jan 2026 Sep 2026 $0.369 $0.241
▲ Up 19% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
00574-7050-12 You're viewing this 12 BLISTER PACK in 1 CARTON / 1 SUPPOSITORY in 1 BLISTER PACK $0.3197 / ea $3.84 1990-09-01 — Active
00574-7050-50 0574-7050-50 Main listing 50 BLISTER PACK in 1 CARTON / 1 SUPPOSITORY in 1 BLISTER PACK $0.3197 / ea $15.99 1990-09-01 — Active

This pack has the lowest per-ea cost of the 2 priced pack sizes ($0.3197 NADAC).

This pack accounts for about 47% of this product's recent Medicaid fills; most go to a different pack size. See all packs ↓

Pack size FAQ

What quantity is in this package?
This package contains 12 suppositories — 12 blister pack in 1 carton / 1 suppository in 1 blister pack.
How does this package differ from NDC 00574-7050-50?
Both are Bisacodyl 10 mg Suppository — the drug itself is identical. This page's package is the 12 suppositories one, while NDC 00574-7050-50 is the 50 suppositories package.
What NDC number is used to bill for this package of Bisacodyl 10 mg Suppository?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Bisacodyl 10 mgthis 00574-7050-12 Padagis 12 suppositories $0.320 — Availability likely —
Bisacodyl 10 mg 00904-7142-12 Major 12 suppositories $0.320 — Availability likely —
Good Neighbor Pharmacy Gentle Laxative 10 mg/2000mg 46122-0608-51 AmerisourceBergen 40 mg $0.320 — Availability likely —
Bisacodyl 10 mg 57237-0327-03 Rising 30 suppositories $0.320 — Availability likely —
Proctozone-B 10 mg 57237-0337-03 Rising 30 suppositories $0.320 — Availability likely —
Bisacodyl 10 mg 70000-0573-01 Cardinal 4 suppositories $0.320 — Availability likely —
Foster and Thrive Gentle Laxative 10 mg/2000mg 70677-1091-01 Strategic 40 mg $0.320 — Availability likely —
Walgreens Gentle Laxative 10 mg 00363-0466-04 Walgreens 40 mg — — FDA listed —
Walgreens Gentle Laxative 10 mg 00363-0468-04 Walgreens 4 suppositories — — FDA listed —
Rite-Aid Gentle Laxative 10 mg 11822-4890-05 RITE 8 suppositories — — FDA listed —
Gentle Laxative Bisacodyl 10 mg 13709-0321-01 NeilMed 30 capsules — — FDA listed —
Bisacodyl Laxative 10 mg/1.8g 13709-0328-01 Neilmed 1.8 g — — FDA listed —
HEB Gentle Laxative 10 mg/2000mg 37808-0877-08 H 40 mg — — FDA listed —
Dulcolax Laxative 10 mg 41167-0210-01 Chattem, 4 suppositories — — FDA listed —
Meijer Gentle Laxative 10 mg/2000mg 41250-0665-04 Meijer 40 mg — — FDA listed —
Discount Drugmart Gentle Laxative 10 mg/2000mg 53943-0805-08 Discount 40 mg — — FDA listed —
Dollar General Gentle Laxative 10 mg/2000mg 55910-0457-04 Dolgencorp, 40 mg — — FDA listed —
Bisacodyl 10 mg 57896-0443-01 GERI-CARE 100 suppositories — — FDA listed —
Stratuscare Bisacodyl 10 mg 58980-0415-04 Stratus 4 suppositories — — FDA listed —
CVS Gentle Laxative 10 mg 59779-0107-09 CVS 8 suppositories — — FDA listed —
Bisacodyl 10 mg 68016-0084-08 Pharmacy 8 suppositories — — FDA listed —
Bisacodyl 10 mg 69842-0816-04 CVS 4 suppositories — — FDA listed —
Laxative 10 mg 70795-1010-01 GRAXCELL 100 suppositories — — FDA listed —
OneLAX 10 mg 71399-8460-02 AKRON 12 suppositories — — FDA listed —
Conlax 10 mg 72701-0102-04 Bliss 4 suppositories — — FDA listed —
Bisacodyl 10 mg 82568-0028-02 AARNA 12 suppositories — — FDA listed —
Bisacodyl 10 mg 83720-0550-25 Oncor 12 suppositories — — FDA listed —
Bisacodyl Laxative 10 mg 71457-0501-01 InvaDerm 102 suppositories — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
1990
On the market since
Sep 1990
📍
2026
Currently FDA-listed
36 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color White
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII FM8D1RE2VP
    A plant-based oil that has been chemically hardened to stay solid at room temperature. It works as a binder and lubricant to hold tablet ingredients together and help them release properly during digestion.

1 inactive ingredient listed in the exact product block matched to this NDC.

The official label also stateshydrogenated palm kernel oil

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerPadagis US LLC
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code00574
First marketedSep 1990
Product typeHuman Otc Drug
Portfolio63 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Ask a Doctor Before Use If 📄 Ask a Doctor or Pharmacist Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 23 words ▾

Use • for temporary relief of occasional constipation and irregularity • this product generally produces bowel movement in 15 minutes to 1 hour

⏱️ Dosage and Administration 58 words ▾

Directions adults and children 12 years of age and over 1 suppository in a single daily dose. Pull apart foil. Insert suppository well into rectum, pointed end first. Retain about 15 to 20 minutes. children 6 to under 12 years of age ½ suppository in a single daily dose children under 6 years of age ask a doctor

⚠️ Warnings 123 words ▾

Warnings For rectal use only Ask a doctor before use if you have • stomach pain, nausea or vomiting • a sudden change in bowel habits that lasts more than 2 weeks Ask a doctor or pharmacist before use if you are taking any other drug. Take this product two or more hours before or after other drugs. Laxatives may affect how other drugs work.

When using this product it may cause stomach discomfort, faintness, rectal burning and milk cramps Stop use and ask a doctor if • you have rectal bleeding or fail to have a bowel movement after use of a laxative because this may indicate a serious condition • you need to use a laxative for more than 1 week

📦 Storage and Handling 7 words ▾

Other information • store at 20-25°C (68-77°F)

🧪 Active Ingredient 9 words ▾

Active ingredient (in each suppository) Bisacodyl USP 10 mg

🧪 Inactive Ingredients 6 words ▾

Inactive ingredients hydrogenated palm kernel oil

🎯 Purpose 3 words ▾

Purpose Stimulant laxative

📄 Ask a Doctor Before Use If 27 words ▾

Ask a doctor before use if you have • stomach pain, nausea or vomiting • a sudden change in bowel habits that lasts more than 2 weeks

📄 Ask a Doctor or Pharmacist Before Use If 33 words ▾

Ask a doctor or pharmacist before use if you are taking any other drug. Take this product two or more hours before or after other drugs. Laxatives may affect how other drugs work.

📄 When Using This Product 15 words ▾

When using this product it may cause stomach discomfort, faintness, rectal burning and milk cramps

📄 Stop Use and Ask a Doctor If 43 words ▾

Stop use and ask a doctor if • you have rectal bleeding or fail to have a bowel movement after use of a laxative because this may indicate a serious condition • you need to use a laxative for more than 1 week

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 20 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

📄 Questions or Comments 4 words ▾

Questions or comments? 1-866-634-9120

📄 Package Label / Principal Display Panel 18 words ▾

Package/Label Principal Display Panel NDC 0574-7050-12 Bisacodyl Suppositories, USP 10 mg Stimulant Laxative UNIT DOSE 12 Suppositories carton

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
46.5K
Units reimbursed last 4 qtrs
803.9K
Gross reimbursed last 4 qtrs
$541.2K
Avg / prescription
$11.64
Avg / unit
$0.6733
Latest quarter Q1 2026
9.4KRx
Medicaid pays / ea
$0.6733
gross reimbursed
vs
NADAC / ea
$0.3197
acquisition cost
=
Spread
+$0.3536
+111% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
66% FFS 34% MCO
Fee-for-service · 30,652 Rx Managed care · 15,834 Rx
State Medicaid map
Alaska: no data reported AK Maine: 5,110 units · 366 per 100k residents ME Washington: 19,021 units · 243 per 100k residents WA Idaho: no data reported ID Montana: 2,927 units · 259 per 100k residents MT North Dakota: no data reported ND Minnesota: 35,541 units · 620 per 100k residents MN Wisconsin: 2,345 units · 39.7 per 100k residents WI Michigan: 34,603 units · 345 per 100k residents MI New York: 168,998 units · 864 per 100k residents NY Vermont: 811 units · 125 per 100k residents VT New Hampshire: 1,190 units · 84.9 per 100k residents NH Oregon: 13,877 units · 328 per 100k residents OR Nevada: 3,450 units · 108 per 100k residents NV Wyoming: 1,241 units · 213 per 100k residents WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: 8,647 units · 68.9 per 100k residents IL Indiana: 20,026 units · 292 per 100k residents IN Ohio: 39,426 units · 335 per 100k residents OH Pennsylvania: 48,461 units · 374 per 100k residents PA New Jersey: 21,602 units · 233 per 100k residents NJ Massachusetts: 25,887 units · 370 per 100k residents MA California: 222,701 units · 572 per 100k residents CA Utah: 2,492 units · 72.9 per 100k residents UT Colorado: 11,829 units · 201 per 100k residents CO Nebraska: 9,654 units · 488 per 100k residents NE Missouri: 11,550 units · 186 per 100k residents MO Kentucky: 15,094 units · 333 per 100k residents KY West Virginia: no data reported WV Virginia: 11,191 units · 128 per 100k residents VA Maryland: 2,048 units · 33.1 per 100k residents MD Connecticut: 7,547 units · 209 per 100k residents CT Rhode Island: 2,010 units · 184 per 100k residents RI Arizona: 7,592 units · 102 per 100k residents AZ New Mexico: 887 units · 42.0 per 100k residents NM Kansas: 3,055 units · 104 per 100k residents KS Arkansas: 216 units · 7.0 per 100k residents AR Tennessee: 3,564 units · 50.0 per 100k residents TN North Carolina: no data reported NC South Carolina: 392 units · 7.3 per 100k residents SC Delaware: 1,457 units · 141 per 100k residents DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: 1,123 units · 10.2 per 100k residents GA D.C.: 1,650 units · 243 per 100k residents DC Hawaii: 1,180 units · 82.2 per 100k residents HI Texas: 33,458 units · 110 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
7.0864
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 New York 864 /100k
2 Minnesota 620 /100k
3 California 572 /100k
4 Nebraska 488 /100k
5 Pennsylvania 374 /100k
6 Massachusetts 370 /100k
7 Maine 366 /100k
8 Michigan 345 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
50 suppositories00574-7050-50 52,107 Rx · $607,009
12 suppositories this page00574-7050-12 46,486 Rx · $541,212
Drug total (last 4 qtrs): 98,593 Rx · 1,716,982 units · $1,148,222 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.
← 00574-7045-04 · Padagis 00574-7090-12 · Padagis →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.